The weekly litigation news digest is live. Subscribe now

IP Verse

Celator Pharmaceuticals competitive analysis

Loading summary...

Latest patents of Celator Pharmaceuticals opposed by its competitors

Explore Celator Pharmaceuticals's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Nov 20, 2025
Patent NumberPublication DateTitleTotal Oppositions
EP3300601
Jan 12, 2022Fixed Drug Ratios For Treatment Of Hematopoietic Cancers And Proliferative Disorders3
EP2768484
Jul 24, 2019Lyophilized Liposomes2
EP2120568
Nov 15, 2017Fixed Drug Ratios For Treatment Of Hematopoietic Cancers And Proliferative Disorders2

Latest PTAB cases involving Celator Pharmaceuticals

Discover the latest PTAB cases involving Celator Pharmaceuticals, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Celator Pharmaceuticals with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Nov 20, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
CELATOR PHARMACEUTICALS - 7 - -
D YOUNG29 - - -
GENERICS UK214 - - -
SANDOZ1191619 -